Subcutaneous tumor formation assay by which tumor volume and dissected tumor weight was determined, clearly showed that knockdown of SIRT3 promoted prostate cancer growth in vivo (Figure 3H–3J). Here, SIRT3 is linked to prostate carcinoma.